SHC · Sotera Health Co · Executive Compensation

$18.10 -0.03 (-0.17%) At close · Oct 23

S&P 400 member Russell 1000 member Rebalance outlook locked

Market Cap

$5.17B

285.37M

Volume · Oct 23 1.69M Avg daily vol (3M) 2.33M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael B. Petras	Chairman and CEO	$1,050,000	—	$3,749,995	$3,745,697	$1,137,938	$17,375	$9,701,005
Jonathan M. Lyons	SVP, CFO	$237,500	$200,000	$1,299,973	$298,791	$141,312	—	$2,177,576
Michael P. Rutz	President of Sterigenics	$464,615	$300,000	$499,996	$499,424	$249,498	$16,706	$2,030,239
Alexander Dimitrief	SVP, General Counsel and Secretary	$600,000	—	—	—	$260,100	$2,077	$862,177
Michael F. Biehl	Former Interim CFO	$553,846	—	—	—	—	—	$553,846
Michael Biehl	Former Interim CFO	$553,846	—	—	—	—	—	$553,846

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael B. Petras	Chairman and CEO	$1,038,462	—	$3,749,997	$10,712,705	$1,142,308	$16,386	$16,659,858
Alexander Dimitrief	SVP, General Counsel and Secretary	$90,000	$1,500,000	$1,499,995	$1,991,351	$39,600	$1,038	$5,121,984
Terrence G. Hammons	Former SVP, General Counsel and Secretary	$335,000	$500,000	$449,994	$447,496	—	$165,705	$1,898,195
Scott Leffler	Former CFO and Treasurer	$305,769	—	$749,983	$745,834	—	$16,855	$1,818,441
Michael P. Rutz	President of Sterigenics	$445,385	—	$499,989	$497,220	$253,201	$17,146	$1,712,941
Matthew J. Klaben	Former Interim SVP, General Counsel and Secretary	$318,115	—	$437,482	$174,027	$95,129	$13,514	$1,038,267
Michael F. Biehl	Former Interim CFO	$415,385	—	—	—	—	—	$415,385
Michael Biehl	Former Interim CFO	$415,385	—	—	—	—	—	$415,385

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael B. Petras	Chairman and CEO	$1,000,000	—	—	—	$1,137,500	$60,074	$2,197,574
Scott Leffler	Former CFO and Treasurer	$450,000	—	—	—	$292,383	$13,050	$755,433
Michael P. Rutz	President of Sterigenics	$430,000	—	—	—	$246,390	$13,050	$689,440
Terrence G. Hammons	Former SVP, General Counsel and Secretary	$65,385	—	$200,000	$300,000	$29,750	$490	$595,625
Matthew J. Klaben	Former Interim SVP, General Counsel and Secretary	$405,769	—	—	—	$176,225	$13,050	$595,044

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael B. Petras	Chairman and CEO	$727,692	$700,000	$6,000,000	$9,000,000	$738,957	$37,609	$17,204,248
Michael P. Rutz	President of Sterigenics	$269,577	$50,000	$4,800,000	$900,000	$153,133	$10,623	$6,183,333
Scott Leffler	Former CFO and Treasurer	$369,805	$225,000	$1,200,000	$1,800,000	$222,113	$24,913	$3,841,831

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael B. Petras	Chairman and Chief Executive Officer	$700,000	$1,000,000	—	—	$759,500	$12,600	$2,472,100
Scott Leffler	Chief Financial Officer and Treasurer	$352,135	$1,650,000	—	—	$229,240	$12,600	$2,243,975

Executive changes

Person	Role	Change	Effective	Filed
James C. Neary	Class I director	Resigned	2026-08-13	2026-08-14
Michael B. Petras, Jr.	Executive Chairman	Appointed	2026-05-26	2026-05-05
Alton Shader	Class II director of the Board	Appointed	2026-05-26	2026-05-05
Alton Shader	Chief Executive Officer	Appointed	2026-05-26	2026-05-05
Kenneth D. Krause	Class I director	Appointed	2026-03-16	2026-03-16
Constantine S. Mihas	Class I director	Resigned	2026-03-16	2026-03-16
Erika Ostrowski	Senior Vice President and General Counsel	Appointed	2026-04-01	2026-02-24
Alex Dimitrief	Senior Vice President and General Counsel	Retired	2026-03-31	2026-02-24
Richard G. Kyle	Class III director	Appointed	2026-02-04	2026-02-05
David A. Donnini	director	Resigned	2024-09-06	2024-09-06
Christopher A. Simon	Class III director of the Board	Appointed	2024-08-01	2024-08-01
Karen A. Flynn	director	Appointed	2023-11-13	2023-11-13
Jonathan M. Lyons	Senior Vice President and Chief Financial Officer	Appointed	2023-06-26	2023-06-26
Robert B. Knauss	director	Appointed	2022-10-12	2022-10-13
Stephanie M. Geveda	director	Resigned	2022-10-07	2022-10-13
Matthew Klaben	Interim Senior Vice President, General Counsel and Secretary	Appointed	2022-10-01	2022-09-06
Michael F. Biehl	Interim Chief Financial Officer	Appointed	2022-07-20	2022-07-20

Leadership

Alton Shader CEO, Board Member
Michael B. Petras, Jr. Chairman
Michael F. Biehl CFO
Erika Ostrowski General Counsel
Matthew J. Klaben General Counsel
Matthew Klaben General Counsel
Terrence G. Hammons General Counsel
Chistopher A. Simon Board Member
Christopher A. Simon Board Member
Kenneth D. Krause Board Member
Richard G. Kyle Board Member
Sean L. Cunningham Board Member
Vincent K. Petrella Board Member

Key facts CIK 1822479 CUSIP 83601L102 13F (30d) 40 filings 40 filers Visit website Investor relations